X0002

· Tianjin XinChen-Techfields Pharma Co., LTD.

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for X0002, covering 2020-01-13 to 2023-03-07. Get the full timeline:

Most recent: Clinical Trial Update: Evaluate Efficacy and Safety of X0002 in Treatment of Knee Osteoarthritis [Phase 3]